Culturally Tailored Decision Aid for Hispanic Patients Diagnosed With Prostate Cancer



Status:Recruiting
Conditions:Prostate Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:9/8/2018
Start Date:August 1, 2017
End Date:December 2019
Contact:Simon P Kim, MD, MPH
Email:Simon.Kim@uhhospitals.org
Phone:216-844-3009

Use our guide to learn which trials are right for you!

Development and Testing of a Culturally Tailored Decision Aid for Hispanic Patients Diagnosed With Prostate Cancer

A pilot study testing the effect of an in-visit English and Spanish language decision aid for
Hispanic-Latino men using best practices of cultural tailoring to be used in urology
practice. Subjects will be followed for approximately 1 year during standard care in-clinic
office visits. Study results and subject surveys will be analyzed to determine clinical
utility of the tool.

The objective of this research is to determine the effect of a culturally tailored decision
aid tool on the cancer treatment decisions of Hispanic-Latino patients.

The specific aims are:

i. To develop and pilot test in an uncontrolled fashion an in-visit English and Spanish
language decision aid for Hispanic-Latino men using best practices of cultural tailoring to
be used in urology practice ii. To pilot and test the impact of a culturally tailored,
English and Spanish language version of the Prostate Choice in-visit decision aid on decision
quality, knowledge, and quality of life in low-income Hispanic/Latino patients diagnosed with
localized prostate cancer iii. To assess the barriers and facilitators of decision aid use
including the relative contribution of language-concordance on 1-year practice implementation
parameters.

Inclusion Criteria:

- Subjects utilize English or Spanish as their primary spoken or written language and
identify with a Latino ethnicity and/or culture

- Men with a new histologic diagnosis of localized prostate cancer

- PSA level of 0.1 - 50 ng/dl

- Gleason score of 6 - 10

- Cancer stage: T1 - 4N x M0

Exclusion Criteria:

- Metastatic disease, including lymph nodes or distant metastasis

- PSA > 50 ng/dl

- Individuals with a medical condition that necessitates a specific prostate cancer
treatment plan

- Individuals that are unwilling or unable to attend study visits or are planning to
move out of a study site coverage area during the subject's anticipated participation
in the study
We found this trial at
4
sites
2500 Metrohealth Dr
Cleveland, Ohio 44109
(216) 778-7800
Phone: 216-778-4391
MetroHealth Med Ctr The MetroHealth System is one of the largest, most comprehensive health care...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
1969 W Ogden Ave
Chicago, Illinois 60612
(312) 864-6000
Phone: 312-864-0913
John H. Stroger, Jr. Hospital of Cook County The Level 1 Trauma Center is one...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Galveston, Texas
Phone: 409-772-2091
?
mi
from
Galveston, TX
Click here to add this to my saved trials